| Literature DB >> 22078363 |
Yoshiharu Sato1, Akiko Takaya, Tomoko Yamamoto.
Abstract
BACKGROUND: Many pathogens use a type III secretion system to translocate virulence proteins (called effectors) in order to adapt to the host environment. To date, many prediction tools for effector identification have been developed. However, these tools are insufficiently accurate for producing a list of putative effectors that can be applied directly for labor-intensive experimental verification. This also suggests that important features of effectors have yet to be fully characterized.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22078363 PMCID: PMC3240867 DOI: 10.1186/1471-2105-12-442
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Statistics for features used in the SVM part of discriminant analysis
| Known effectors | Proteome | |||
|---|---|---|---|---|
| Average | Standard deviation | Average | Standard deviation | |
| GC | ± 0.05 | 0.52 | ± 0.05 | |
| CAI | ± 0.04 | 0.68 | ± 0.06 | |
| N-terminal instability | ± 6.67 | 3.97 | ± 5.52 | |
| Molecular Weight | 40.79 | ± 19.49 | 34.53 | ± 24.50 |
| Charge | ± 11.08 | -2.62 | ± 12.66 | |
| pI | ± 1.51 | 7.04 | ± 1.88 | |
| Instability index | ± 8.57 | 37.77 | ± 10.83 | |
| Aliphatic index | ± 10.53 | 95.32 | ± 17.25 | |
| GRAVY score | ± 0.25 | -0.06 | ± 0.44 | |
| dN/dS | ± 0.30 | 0.20 | ± 0.31 | |
Parameters with statistically significant difference between known effectors and the proteome (Student's t-test, p-value < = 0.05) are shown in bold.
Predictive powers for the various combinations of feature values in the LT2 validation
| AUC | RANKavg | # of TPs in top 20 | |
|---|---|---|---|
| ALL | 0.993 | 40.5 | 9.7 |
| ALL-Nterminal Stability | 0.989 | 57.9 | 7.6 |
| ALL-CAI | 0.991 | 48.4 | 8.9 |
| ALL-ProtParam | 0.989 | 56.7 | 7.9 |
| ALL-dN/dS | 0.992 | 43.9 | 9.1 |
Average AUC values are shown for the four sets of validation models. The RANKavg column shows the average rank of known effectors for 10 validation sets. The average number of true positives from 20 known testing examples in the top 20 is shown in the right column.
Figure 1ROC curves of the performance of different prediction tools for N-terminal instability. The values for sensitivity and specificity were averaged for ten validation sets. To remove the effect of abundant negative examples, the top 200 ranked genes were selected and the ROC curve was created from these.
Figure 2Refinement of predictive power by additional filtering in the LT2 internal model. 'SVM(ALL)' represents the distribution of true positive counts as a function of the count of predictions for top-50 ranking in SVM portion of the analysis. The true positive count of 'SVM+Filtering' was re-estimated for prediction ranking after simple-criteria-based filtering. The true positive count for the respective total prediction count was the average of 10 randomly selected validation sets.
Putative novel effectors of serovar Typhimurium predicted by the system
| Rank | STM-ID | Name | Description | PSOTb 3.0 | Ref. # | Poodle-S |
|---|---|---|---|---|---|---|
| 3 | STM1087 | pathogenicity island encoded protein: SPI3 | Cytoplasmic | [ | 13 | |
| 4 | STM1055 | Gifsy-2 prophage | Unknown | [ | 17 | |
| 32 | STM3155 | putative cytoplasmic protein | Unknown | [ | 18 | |
| 40 | STM1239 | putative cytoplasmic protein | Cytoplasmic | - | 11 | |
| 41 | STM2534 | putative cytoplasmic protein | Cytoplasmic | - | 12 | |
| 42 | STM2007 | putative TPR repeat protein | Extracellular | [ | 7 | |
| 43 | STM1670 | putative serine/threonine protein kinase | Unknown | [ | 16 | |
| 44 | STM3278 | putative cytoplasmic protein | Unknown | [ | 9 | |
| 45 | STM2761 | putative inner membrane protein | Cytoplasmic | [ | 10 | |
| 46 | STM4504 | putative cytoplasmic protein | Cytoplasmic | [ | 3 | |
| 47 | STM0335 | putative outer membrane protein | Unknown | - | 4 | |
| 48 | STM2139 | putative inner membrane protein | Unknown | [ | 24 | |
| 49 | STM2779 | putative inner membrane protein | Unknown | - | 21 | |
| 50 | STM1554 | putative coiled-coil protein | Unknown | [ | 13 | |
| 51 | STM4302 | putative cytoplasmic protein | Unknown | [ | 15 | |
| 52 | STM1939 | putative glucose-6-phosphate dehydrogenase | Unknown | [ | 13 | |
| 53 | STM3052 | putative outer membrane protein | Unknown | [ | 8 | |
| 54 | STM2879 | chaparone, related to virulence | Cytoplasmic | - | 9 | |
| 55 | STM0497 | putative periplasmic protein | Unknown | - | 10 | |
| 56 | STM2585 | Gifsy-1 prophage: similar to transpose | Unknown | [ | 12 | |
| 57 | STM2008 | putative periplasmic protein | Unknown | [ | 8 | |
| 58 | STM2893 | Surface presentation of antigens; secretory proteins | Cytoplasmic | [ | 10 | |
| 59 | STM1669 | Homology to invasin C of | OuterMembrane | [ | 9 | |
| 60 | STM1940 | putative cell wall-associated hydrolase | Unknown | - | 14 | |
#---References for virulence annotation from the high throughput experiments. The list of references is described in Additional file 9 'Supp_Table_VirlenceAnnot.xls'.